Abo Bibliothek: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Insights into the Approach, Fabrication, Application, and Lacunae of Nanoemulsions in Drug Delivery Systems

Volumen 37, Ausgabe 6, 2020, pp. 511-551
DOI: 10.1615/CritRevTherDrugCarrierSyst.2020030291
Get accessGet access

ABSTRAKT

Many of the recently approved drug molecules that are therapeutically successful are found to be incompatible for the development of a novel delivery system and to take part in various health care management. Regardless of having better therapeutic properties, these molecules are barred from their effective clinical uses. The main reason attributed to it is poor solubility and/or poor permeability of drugs which finally emerges the drug to be low bioavailable. Nanoemulsions are one of the most acceptable nanolipoidal drug delivery system and appears to be a hope for the delivery of many of the Biopharmaceutical Classification System (BCS) class II and IV drugs. A nanoemulsion is a thermodynamically unstable isotropic mixture of oil, surfactant, and co-surfactants and is biphasic in nature. It can be either water in oil or oil in water and droplets are found in the range of 5 to 500 nm. The manufacturing and fabrication of nanoemulsions involve various natural, synthetic and semi synthetic materials using either low or high-energy methods. Application of nanoemulsions as a novel drug delivery system through several routes, especially oral, transdermal, ophthalmic, and intranasal, have been increased for various pharmacological aspects such as cardiovascular, anticancer, antimicrobial, and ophthalmic due to their stability, high solubilization capacity, and ease of preparation. The objective of this review is to focus on the aspects of manufacturing, fabrication, application, and some toxicological concerns related to nanoemulsions.

REFERENZEN
  1. Kumar N, Gupta S, Dube A, Vyas SP. Emerging role of vesicular carriers for therapy of visceral leishmaniasis: Conventional versus novel. Crit Rev Ther Drug Carrier Syst. 2010;27(6):461-507.

  2. Mundada V, Patel M, Sawant K. Submicron emulsions and their applications in oral delivery. Crit Rev Ther Drug Carrier Syst. 2016;33(3):265-308.

  3. Lazar LF, Olteanu ED, Iuga R, Burz C, Achim M, Clichici S, Tefas LR, Nenu I, Tudor D, Baldea I, Filip GA. Solid lipid nanoparticles: Vital characteristics and prospective applications in cancer treatment. Crit Rev Ther Drug Carrier Syst. 2019;36(6):537-81.

  4. Rahman M, Beg S, Anwar F, Kumar V, Ubale R, Addo RT, Ali R, Akhter S. Liposome-based nano-medicine therapeutics for rheumatoid arthritis. Crit Rev Ther Drug Carrier Syst. 2017;34(4)283-316.

  5. McClements DJ. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter. 2012;8(6):1719-29.

  6. Jasmina H, Dzana O, Alisa E, Edina V, Ognjenka R. Preparation of nanoemulsions by high-energy and low energy emulsification methods. In: CMBEBIH. Singapore: Springer; 2017. p. 317-22.

  7. Singh B, Beg S, Khurana RK, Sandhu PS, Kaur R, Katare OP. Recent advances in self-emulsifying drug delivery systems (SEDDS). Crit Rev Ther Drug Carrier Syst. 2014;31(2)121-85.

  8. Djekic L, Jankovic J, Calija B, Primorac M. Development of semisolid self-microemulsifying drug delivery systems (SMEDDSs) filled in hard capsules for oral delivery of acyclovir. Int J Pharmaceut. 2017;528(1-2):372-80.

  9. Truong DH, Tran TH, Ramasamy T, Choi JY, Lee HH, Moon C, Choi HG, Yong CS, Kim JO. Development of solid self-emulsifying formulation for improving the oral bioavailability of erlotinib. Aaps Pharmscitech. 2016;17(2):466-73.

  10. Hamed AC, Vitthal VC, Pravin DC. Self-emulsifying drug delivery system: A review. Int J Pharm Chem Sci. 2013;2(1):34-44.

  11. Reiss H. Entropy-induced dispersion of bulk liquids. J Colloids Interface Sci. 1975;53:61-70.

  12. Singh G, Khinchi MP, Gupta MK, Agrawal D, Hussain A, Sharma N. Self-emulsifying drug delivery systems (SEEDS): An approach for delivery of poorly water soluble drug. Int J Pharm Life Sci. 2012;3(9):1991.

  13. Patel BR, Patel PR, Patel M. Self-emulsifying drug delivery systems. Pharm Sci Tech. 2008;7:1-3.

  14. Karwal R, Garg T, Rath G, Markandeywar TS. Current trends in self-emulsifying drug delivery systems (SEDDSs) to enhance the bioavailability of poorly water-soluble drugs. Crit Rev Ther Drug Carrier Syst. 2016;33(1):1-39.

  15. Krstic M, Medarevic B, Buris J, Ibric S. Self-nanoemulsifying drug delivery systems (SNEDDS) and self-microemulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs. In: Lipid nanocarriers for drug targeting. New York: William Andrew Publishing; 2018. p. 473-508.

  16. Wakerly MG, Pouton CW, Meakin BJ, Morton FS. Self-emulsification of vegetable oil-nonionic surfactant mixtures: A proposed mechanism of action. In ACS symp. Ser 1986 Jan 1 (Vol. 311, pp. 242-55).

  17. Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: Efficacy, acute local toxicity, and reversibility. Pharm Res. 1994;11(8):1132-42.

  18. Buyukozturk F, Benneyan JC, Carrier RL. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release. 2010;142(1):22-30.

  19. Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Exp Opin Drug Deliv. 2006;3(1):97-110.

  20. Morozowich W, Gao P, Charton M. Speeding the development of poorly soluble/poorly permeable drugs by SEDDS/S-SEDDS formulations and prodrugs. Part 1. Am Pharm Rev. 2006;9:110-4.

  21. Gao P, Charton M, Morozowich W. Speeding the development of poorly soluble/poorly permeable drugs by SEDDS/S-SEDDS formulations and prodrugs. Part 2. Am Pharm Rev. 2006;9:16-23.

  22. Serajuddin AT, Mufson D, Bernstein DF, Sheen PC, Augustine MA. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J Pharm Sci. 1988;77(5):414-7.

  23. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J. Pharm. 1994;106(1):15-23.

  24. Singh B, Bandopadhyay S, Kapil R, Singh R, Katare OP. Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 2009;26(5):427-521.

  25. Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: Preparation techniques and dosage forms. Drug Discov Today. 2008;13(13-14):606-12.

  26. Kyatanwas AU, Gajdhiye ND, Jadhav KR, Kadam VJ. Solid self-emulsifying drug delivery system: A review. J Pharm Res. 2010;3(4):877-82.

  27. Wadhwa J, Nair A, Kumria R. Emulsion forming drug delivery system for lipophilic drugs. Acta Pol Pharm. 2012;69(2):179-91.

  28. Shaji J, Jadhav D. Newer approaches to self-emulsifying drug delivery system. Int J Pharm Pharm Sci. 2010;2(1):37-42.

  29. PP M, Makanikar V, Parekh PP. Self-emulsifying drug delivery system: A novel approach to enhance oral bioavailability of poorly soluble drugs. J Pharm Res. 2011 Jul;4(7):2191-4.

  30. Kumar A, Sharma S, Kamble R. Self-emulsifying drug delivery system (SEDDS): Future aspects. Int J Pharm Pharm Sci. 2010;2(4):7-13.

  31. Pandey V, Kohli S. Lipids and surfactants: The inside story of lipid-based drug delivery systems. Crit Rev Ther Drug Carrier Syst. 2018;35(2):99-155.

  32. Pouton CW. Effects of the inclusion of a model drug on the performance of self-emulsifying formulations. J Pharm Pharmacol. 1985;37(S12):1P.

  33. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992;9(1):87-93.

  34. Nasr A, Gardouh A, Ghorab M. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: Design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 2016;8(3):20.

  35. Chanana GD, Sheth BB. Particle size reduction of emulsions by formulation design-II: Effect of oil and surfactant concentration. PDA J Pharm Sci Technol. 1995;49(2):71-6.

  36. Kimura M, Shizuki M, Miyoshi K, Sakai T, Hidaka H, Takamura H, Matoba T. Relationship between the molecular structures and emulsification properties of edible oils. Biosci Biotechnol Biochem. 1994;58(7):1258-61.

  37. Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci. 1998;87(2):164-9.

  38. Karim A, Gokhale R, Cole M, Sherman J, Yeramian P, Bryant M, Franke H. HIV protease inhibitor SC-52151: A novel method of optimizing bioavailability profile via a microemulsion drug delivery system. Pharm Res. 1994;11:S368.

  39. Udaya SM, Josephine RLF, Kiran BU. Self nano emulsifying drug delivery systems for oral delivery of hydrophobic drugs. Biomed Pharmacol J. 2013;6(2):355-62.

  40. Obitte NC, Ofokansi KC, Nzekwe IT, Esimone CO, Okoye IE. Self-nanoemulsifying drug delivery systems based on melon oil and its admixture with a homolipid from Bos indicus for the delivery of indomethacin. Trop J Pharm Res. 2011;10(3):299-307.

  41. Thomas N, Holm R, Garmer M, Karlsson JJ, Mullertz A, Rades T. Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. AAPS J. 2013;15(1):219-27.

  42. Shukla M, Jaiswal S, Sharma A, Srivastava PK, Arya A, Dwivedi AK, Lal J. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anti-cancer efficacy of curcumin. Drug Dev Indust Pharm. 2017;43(5):847-61.

  43. Sandhu PS, Beg S, Mehta F, Singh B, Trivedi P. Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: Implications on cytotoxicity and biopharmaceutical performance. Exp Opin Drug Deliv. 2015;12(11):1809-22.

  44. Mohsin K, Rayan Alamri AA, Raish M, Alanazi FK, Hussain MD. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. Int J Nanomed. 2016;11:2829-38.

  45. Chai F, Sun L, Ding Y, Liu X, Zhang Y, Webster TJ, Zheng C. A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability. Nanomedicine. 2016;11(14):1801-16.

  46. Prajapati ST, Joshi HA, Patel CN. Preparation and characterization of self-microemulsifying drug delivery system of olmesartan medoxomil for bioavailability improvement. J Pharm. 2012;2013:728425.

  47. Kang MJ, Kim HS, Jeon HS, Park JH, Lee BS, Ahn BK, Moon KY, Choi YW. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system. Drug Devel Indust Pharm. 2012;38(5):587-96.

  48. Li Z, Zhang W, Gao Y, Xiang R, Liu Y, Hu M, Zhou M, Liu X, Wang Y, He Z, Sun Y. Development of self-nanoemulsifying drug delivery system for oral bioavailability enhancement of valsartan in beagle dogs. Drug Deliv Transl Res. 2017;7(1):100-10.

  49. Zhao K, Yuan Y, Wang H, Li P, Bao Z, Li Y. Preparation and evaluation of valsartan by a novel semi-solid self-microemulsifying delivery system using Gelucire 44/14. Drug Devel Indust Pharm. 2016;42(10):1545-52.

  50. Patel J, Dhingani A, Garala K, Raval M, Sheth N. Quality by design approach for oral bioavailability enhancement of IRB by self-nanoemulsifying tablets. Drug Deliv. 2014;21(6):412-35.

  51. Khattab A, Hassanin L, Zaki N. Self-nanoemulsifying drug delivery system of coenzyme (Q10) with improved dissolution, bioavailability, and protective efficiency on liver fibrosis. AAPS PharmSciTech. 2017;18(5):1657-72.

  52. Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, Talegaonkar S. Nanoemulsion components screening and selection: A technical note. AAPS PharmSciTech. 2009;10(1):69-76.

  53. Pawar KR, Babu RJ. Lipid materials for topical and transdermal delivery of nanoemulsions. Crit Rev Ther Drug Carrier Syst. 2014;31(5):429-58.

  54. McClements DJ, Rao J. Food-grade nanoemulsions: Formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr. 2011;51(4):285-330.

  55. Cannon BJ, Shi Y, Gupta P. Emulsions, microemulsions, and lipid-based drug delivery systems for drug solubilization and delivery. Part I: Parenteral applications. In: Rong L, editor. Water-Insoluble Drug Formulation. New York: Taylor & Francis. 2008; p. 195-226.

  56. Floyd AG. Top ten considerations in the development of parenteral emulsions. Pharm Sci Technol Today. 1999;2(4):134-43.

  57. Strickley RG, Anderson BD. Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery, using extemporaneous emulsions. Pharm Res. 1993;10: 1076-82.

  58. Amala FK, Boby JG, Jeny S, Vinod B, Sunil C. A review on self-emulsifying nanoemulsion. J Pharm Res. 2017;1(4):1-17.

  59. Henry JV, Fryer PJ, Frith WJ, Norton IT. The influence of phospholipids and food proteins on the size and stability of model submicron emulsions. Food Hydrocoll. 2010;24(1):66-71.

  60. Kralova I, Sjoblom J. Surfactants used in food industry: A review. J Dispers Sci Technol. 2009;30(9):1363-83.

  61. Tan CP, Nakajima M. P-carotene nanodispersions: Preparation, characterization and stability evaluation. Food Chem. 2005;92(4):661-71.

  62. Tan CP, Nakajima M. Effect of polyglycerol esters of fatty acids on physicochemical properties and stability of P-carotene nanodispersions prepared by emulsification/evaporation method. J Sci Food Agric. 2005;85(1):121-6.

  63. Yuan Y, Gao Y, Zhao J, Mao L. Characterization and stability evaluation of P-carotene nanoemulsions prepared by high-pressure homogenization under various emulsifying conditions. Food Res Int. 2008;41(1):61-8.

  64. Henry JV, Fryer PJ, Frith WJ, Norton IT. Emulsification mechanism and storage instabilities of hydrocarbon-in-water submicron emulsions stabilised with Tweens (20 and 80), Brij 96v and sucrose monoesters. J Colloid Interface Sci. 2009;338(1):201-6.

  65. Yin LJ, Chu BS, Kobayashi I, Nakajima M. Performance of selected emulsifiers and their combinations in the preparation of carotene nanodispersions. Food Hydrocoll. 2009;23(6):1617-22.

  66. McClements DJ. Emulsion formation. In: Food emulsions: Principles, practice and techniques. Boca Raton, FL: CRC Press; 1999. p. 161-83.

  67. Garti, N. Food emulsifiers: Structure-reactivity relationships, design, and applications. In: Marangoni AG, Narine SS, editors. Physical properties of lipids. Boca Raton, FL: CRC Press; 2002. p. 265-386.

  68. Livney YD. Milk proteins as vehicles for bioactives. Curr Opin Colloid Interface Sci. 2010;15(1-2):73-83.

  69. Foegeding EA, Luck P, Vardhanabhuti B. Milk protein products whey protein products. In: Encyclopedia of dairy science, 2nd ed. San Diego: Academic Press; 2011. p. 873-8.

  70. Hosseinpour S. Changes in the solubility and SDS-PAGE profile of whey proteins during storage at different temperatures: A kinetic study. ISABB J Food Agric Sci. 2011;1(1):15-21.

  71. Tenjarla S. Microemulsions: An overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst. 1999;16(5):461-521.

  72. Dickinson E. Hydrocolloids as emulsifiers and emulsion stabilizers. Food Hydrocolloids. 2009;23(6):1473-82.

  73. Shi Y, Huang G. Recent developments of biodegradable and biocompatible materials based micro/nanoparticles for delivering macromolecular therapeutics. Crit Rev Ther Drug Carrier Syst. 2009;26(1):29-84.

  74. Kang J, Cui SW, Chen J, Phillips GO, Wu Y, Wang Q. New studies on gum ghatti (Anogeissus latifolia) part I. Fractionation, chemical and physical characterization of the gum. Food Hydrocolloids. 2011;25(8):1984-90.

  75. Deshmukh AS, Setty CM, Badiger AM, Muralikrishna KS. Gum ghatti: A promising polysaccharide for pharmaceutical applications. Carbohydrate Polymers. 2012;87(2):980-6.

  76. Anand K, Ray S, Rahman M, Shaharyar A, Bhowmik R, Bera R, Karmakar S. Nano-emulgel: Emerging as a smarter topical lipidic emulsion-based nanocarrier for skin healthcare applications. Recent Pat Antiinfect Drug Discov. 2019;14(1):16-35.

  77. Anton N, Vandamme TF. The universality of low-energy nano-emulsification. Int J Pharm. 2009;377(1-2):142-7.

  78. Mason TG, Graves SM, Wilking JN, Lin MY, Extreme emulsification: Formation and structure of nanoemulsions, J Phys Condens Matter. 2006;9(1):193-9.

  79. Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates: A review. J Control Release. 2008;128(3):185-99.

  80. Sole I, Pey CM, Maestro A, Gonzalez C, Porras M, Solans C, Gutierrez JM. Nano-emulsions prepared by the phase inversion composition method: Preparation variables and scale up. J Colloid Interface Sci. 2010;344(2):417-23.

  81. Quin C, Mc Clement DJ. Formation of nanoemulsions stabilized by model food grade emulsifiers using high-pressure homogenization: Factors effecting particle size. Food Hydrocoll. 2011;25(5): 1000-8.

  82. Jafari SM, He Y, Bhandari B. Optimization of nano-emulsions production by microfluidization. Eur Food Res Technol. 2007;225(5-6):733-41.

  83. Tang SY, Shridharan P, Sivakumar M. Impact of process parameters in the generation of novel asprin nanoemulsions-comparative studies between ultrasound cavitation and microfluidizer. Ultrason Sonochem. 2013;20(1):485-97.

  84. Kamogawa K, Okudaira G, Matsumoto M, Sakai T, Sakai H, Abe M. Preparation of oleic acid/water emulsions in surfactant-free condition by sequential processing using midsonic-megasonic waves. Langmuir. 2004;20(6):2043-7.

  85. Forgiarini A, Esquena J, Gonzalez C, Solans C. Formation of nano-emulsions by low-energy emulsification methods at constant temperature. Langmuir. 2001;17(7):2076-83.

  86. Uson N, Garcia MJ, Solans C. Formation of water-in-oil (W/O) nano-emulsions in a water/mixed non-ionic surfactant/oil systems prepared by a low-energy emulsification method. Colloids Surf A Physicochem Eng Asp. 2004;250(1-3):415-21.

  87. Komaiko JS, McClements DJ. Formation of food-grade nanoemulsions using low-energy preparation methods: A review of available methods. Compr Rev Food Sci Food Saf. 2016;15(2):331-52.

  88. Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies. Adv Drug Deliv Rev. 2008;60(6):625-37.

  89. Chime SA, Kenechukwu FC, Attama AA. Nanoemulsions: Advances in formulation, characterization and applications in drug delivery. Available from: https://www.intechopen.com/books/application-of-nanotechnology-in-drug-delivery/nanoemulsions-advances-in-formulation-characterization-and-applications-in-drug-delivery.

  90. Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, Chourasia MK. Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release. 2017;252:28-49.

  91. Lee SJ, McClements DJ. Fabrication of protein-stabilized nanoemulsions using a combined homogenization and amphiphilic solvent dissolution/evaporation approach. Food Hydrocoll. 2010;24(6-7):560-9.

  92. Jose C, Amra K, Bhavsar C, Momin M, Omri A. Polymeric lipid hybrid nanoparticles: Properties and therapeutic applications. Crit Rev Ther Drug Carrier Syst. 2018;35(6)555-88.

  93. Bouchemal K, Brianjon S, Perrier E, Fessi H. Nano-emulsion formulation using spontaneous emulsification: Solvent, oil and surfactant optimisation. Int J Pharm. 2004;280(1-2):241-51.

  94. Troncoso E, Aguilera JM, McClements DJ. Development of nanoemulsions by an emulsification-evaporation technique. Development of nanoemulsions by an emulsifi cation-evaporation technique. Food Hydrocoll. 2012;27(2):355-63.

  95. Yang Y, Marshall-Breton C, Leser ME, Sher AA, McClements DJ. Fabrication of ultrafine edible emulsions: Comparison of high-energy and low-energy homogenization methods. Food Hydrocoll. 2012;29(2):398-406.

  96. Solans C, Sole I. Nano-emulsions: Formation by low-energy methods. Curr Opin Colloid Interface Sci. 2012;17(5):246-54.

  97. Nagarajan R. Molecular packing parameter and surfactant self-assembly: The neglected role of the surfactant tail. Langmuir. 2002;18(1):31-8.

  98. Maestro A, Sole I, Gonzalez C, Solans C, Gutierrez JM. Influence of the phase behavior on the properties of ionic nanoemulsions prepared by the phase inversion composition method. J Colloid Interface Sci. 2008;327(2):433-9.

  99. Fernandez P, Andre V, Rieger J, Kuhnle A. Nano-emulsion formation by emulsion phase inversion. Colloids Surf A Physicochem Eng Asp. 2004;251(1-3):53-8.

  100. Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev. 2012;64:83-101.

  101. Lakshmi P, Kumar GA. Nanosuspension technology: A review. Int J Pharm Sci. 2010;2(4):35-40.

  102. Hasenhuettl GL, Hartel RW. Food emulsifiers and their applications. New York: Springer; 2008.

  103. Chiesa M, Garg J, Kang YT, Chen G. Thermal conductivity and viscosity of water-in-oil nanoemulsions. Colloids Surf A Physicochem Eng Asp. 2008;326(1-2):67-72.

  104. Fruijtier-Polloth C. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. Toxicology. 2005;214(1-2):1-38.

  105. Rutvij JP, Gunjan JP, Bharadia PD, Pandya VM, Modi DA. Nanoemulsion: An advanced concept of dosage form. Int J Pharm Cosmetol. 2011;1(5):122-33.

  106. Yashpal S, Tanuj H, Harsh K. Nanoemulsions: A pharmaceutical review. Int J Pharma Prof Res. 2014;5(2):1031-8.

  107. Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011;2(05):626-39.

  108. Debnath SU, Satayanarayana Kumar GV. Nanoemulsion: A method to improve the solubility of lipophilic drugs. Pharmanest. 2011;2(2-3):72-83.

  109. Surbhi S, Kumkum S. Nanoemulsions for cosmetics. Int J Adv Res Pharma Bio Sci. 2012;2(3):408-15.

  110. Charoenkul K, Phromyothin D. Development and characterization of nano-cream preparation containing natural extract using nanoemulsion techniques. Mater Today-Proc.2017;4(5): 6105-10.

  111. Simonnet JT, Sonneville O, Legret S, inventors; L'Oreal SA, assignee. Nanoemulsion based on phosphoric acid fatty acid esters and its uses in the cosmetics, dermatological, pharmaceutical, and/or ophthalmological fields. U.S. Patent 6,274,150. 2001 Aug 14.

  112. Simonnet JT, Sonneville O, Legret S, inventors; L Oreal SA, assignee. Nanoemulsion based on ethylene oxide and propylene oxide block copolymers and its uses in the cosmetics, dermatological and/or ophthalmological fields. U.S. Patent 6,464,990. 2002 Oct 15.

  113. Teixeira PC, Leite GM, Domingues RJ, Silva J, Gibbs PA, Ferreira JP. Antimicrobial effects of a microemulsion and a nanoemulsion on enteric and other pathogens and biofilms. Int J Food Microbiol. 2007;118(1):15-9.

  114. Hamouda T, Myc A, Donovan B, Shih AY, Reuter JD, Baker JR. A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol Res. 2001;156(1):1-7.

  115. Hwang YY, Ramalingam K, Bienek DR, Lee V, You T, Alvarez R. Antimicrobial activity of nanoemulsion in combination with cetylpyridinium chloride in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57(8):3568-75.

  116. Tiwari SB, Amiji MM. Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol. 2006;6(9-10):3215-21.

  117. Gaur PK, Mishra S, Purohit S, Dave K. Trans-dermal drug delivery system: A review. Asian J Pharm Clin Res. 2009;2(1):14-20.

  118. Ng KW. Penetration enhancement of topical formulations. Pharmaceutics. 2018;10(2):51.

  119. Mathur V, Satrawala Y, Rajput MS. Physical and chemical penetration enhancers in transdermal drug delivery system. Asian J Pharm. 2014;4(3):173-83.

  120. Cevc G, Vierl U. Nanotechnology and the transdermal route: A state of the art review and critical appraisal. J Control Release. 2010;141(3):277-99.

  121. Kreilgaard M, Pedersen EJ, Jaroszewski JW. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J Control Release. 2000;69(3):421-33.

  122. Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm. 2007;57(3):315-32.

  123. Trotta M, Pattarino F, Gasco MR. Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharmaceutica Acta Helvetiae. 1996;71(2):135-40.

  124. Makhmalzadeh BS, Torabi S, Azarpanah A. Optimization of ibuprofen delivery through rat skin from traditional and novel nanoemulsion formulations. Iran J Pharm Res. 2012;11(1):47-58.

  125. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release. 1997;45(2):131-40.

  126. El-Leithy ES, Ibrahim HK, Sorour RM. In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system. Drug Deliv. 2015;22(8):1010-7.

  127. Alvarez-Figueroa MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: Iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm. 2001;215(1-2):57-65.

  128. Subramanian B, Kuo F, Ada E, Kotyla T, Wilson T, Yoganathan S, Nicolosi R. Enhancement of anti-inflammatory property of aspirin in mice by a nano-emulsion preparation. Int Immunopharmacol. 2008;8(11):1533-9.

  129. Alam MS, Ali MS, Alam N, Siddiqui MR, Shamim M, Safhi MM. In vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis. Drug Invention Today. 2013;5(1):8-12.

  130. Kemken J, Ziegler A, Muller BW. Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle. Pharm Res. 1992; 9(4):554-8.

  131. Kreilgaard M. Dermal pharmacokinetics of microemulsion formulations determined by in vivo micro-dialysis. Pharm Res. 2001;18(3):367-73.

  132. Kreilgaard M, Kemme MJ, Burggraaf J, Schoemaker RC, Cohen AF. Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm Res. 2001;18(5):593-9.

  133. Jeengar MK, Rompicharla SV, Shrivastava S, Chella N, Shastri NR, Naidu VG, Sistla R. Emu oil based nano-emulgel for topical delivery of curcumin. Int J Pharm. 2016;506(1-2):222-36.

  134. Sunitha S, Wankar J, Ajimera T. Design, development and evaluation of nanoemulsion and nanogel of itraconazole for transdermal delivery. J Sci Res Pharm. 2014;3(1):6-11.

  135. Pund S, Pawar S, Gangurde S, Divate D. Transcutaneous delivery of leflunomide nanoemulgel: Mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. Int J Pharm. 2015;487(1-2):148-56.

  136. Harwansh RK, Mukherjee PK, Bahadur S, Biswas R. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci. 2015;141:202-11.

  137. Pratap SB, Brajesh K, Jain SK, Kausar S. Development and characterization of a nanoemulsion gel formulation for transdermal delivery of carvedilol. Int J Drug Devel Res. 2012;4(1):151-61.

  138. Pangeni R, Kang SW, Oak M, Park EY, Park JW. Oral delivery of quercetin in oil-in-water nanoemulsion: In vitro characterization and in vivo anti-obesity efficacy in mice. J Funct Foods. 2017;38:571-81.

  139. Aithal G, Nayak U, Mehta C, Narayan R, Gopalkrishna P, Pandiyan S, Garg S. Localized in situ nanoemulgel drug delivery system of quercetin for periodontitis: Development and computational simulations. Molecules. 2018;23(6):1363.

  140. Hussain A, Singh S, Webster TJ, Ahmad FJ. New perspectives in the topical delivery of optimized amphotericin B loaded nanoemulsions using excipients with innate anti-fungal activities: A mechanistic and histopathological investigation. Nanomed Nanotechnol Biol Med. 2017;13(3):1117-26.

  141. Dal Mas J, Zermiani T, Thiesen LC, Silveira JL, da Silva KA, de Souza MM, Malheiros A, Bresolin TM, Lucinda-Silva RM. Nanoemulsion as a carrier to improve the topical anti-inflammatory activity of stem bark extract of Rapanea ferruginea. Int J Nanomedicine. 2016;11:4495.

  142. Alam MS, Ali MS, Zakir F, Alam N, Alam MI, Ahmad F, Siddiqui MR, Ali MD, Ansari MS, Ahmad S, Ali M. Enhancement of anti-dermatitis potential of clobetasol propionate by DHA [docosahexaenoic acid] rich algal oil nanoemulsion gel. Iran J Pharm Res. 2016;15(1):35-52.

  143. Rodriguez L, Passerini N, Cavallari C, Cini M, Sancin P, Fini A. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int J Pharm. 1999;183(2):133-43.

  144. Alwan A. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.

  145. Kumar S, Bhargava D, Thakkar A, Arora S. Drug carrier systems for solubility enhancement of BCS class II drugs: A critical review. Crit Rev Ther Drug Carrier Syst. 2013;30(3):217-56.

  146. Tan A, Martin A, Nguyen TH, Boyd BJ, Prestidge CA. Hybrid nanomaterials that mimic the food effect: Controlling enzymatic digestion for enhanced oral drug absorption. Angew Chem Int Ed Engl. 2012;51(22):5475-9.

  147. Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007;59(7):667-76.

  148. Khoo SM, Shackleford DM, Porter CJ, Edwards GA, Charman WN. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm Res. 2003;20(9):1460-5.

  149. Constantinides PP, Wasan KM. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: In vitro/in vivo case studies. J Pharm Sci. 2007;96(2):235-48.

  150. Dong X, Mattingly CA, Tseng MT, Cho MJ, Liu Y, Adams VR, Mumper RJ. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res. 2009;69(9):3918-26.

  151. Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6(3):231-48.

  152. Gao F, Zhang Z, Bu H, Huang Y, Gao Z, Shen J, Zhao C, Li Y. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism. J Control Release. 2011;149(2):168-74.

  153. Gorain B, Choudhury H, Kundu A, Sarkar L, Karmakar S, Jaisankar P, Pal TK. Nanoemulsion strategy for olmesartanmedoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces. 2014;115:286-94.

  154. Chhabra G, Chuttani K, Mishra AK, Pathak K. Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Devel Indust Pharm. 2011;37(8):907-16.

  155. Patel J, Patel A, Raval M, Sheth N. Formulation and development of a self-nanoemulsifying drug delivery system of IRB. J Adv Pharm Technol Res. 2011;2(1):9-16.

  156. Patel J, Kevin G, Patel A, Raval M, Sheth N. Design and development of a self-nanoemulsifying drug delivery system for telmisartan for oral drug delivery. Int J Pharm Invest. 2011;1(2):112.

  157. Mahmoud DB, Shukr MH, Bendas ER. In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration. Int J Pharm. 2014;476(1-2):60-9.

  158. Amin MM, El Gazayerly ON, Abd El-Gawad NA, Abd El-Halim SM, El-Awdan SA. Effect of formulation variables on design, in vitro evaluation of valsartan SNEDDS and estimation of its antioxidant effect in adrenaline-induced acute myocardial infarction in rats. Pharm Dev Technol. 2016;21(8):909-20.

  159. Khani S, Keyhanfar F, Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv. 2016;23(6):2035-43.

  160. Aqil M, Kamran M, Ahad A, Imam SS. Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: Box-Behnken design optimization and pharmacokinetic evaluation. J Mol Liq. 2016;214:238-48.

  161. da Silva Marques TZ, Santos-Oliveira R, de Siqueira LB, da Silva Cardoso V, de Freitas ZM, da Silva Ascenjao RD. Development and characterization of a nanoemulsion containing propranolol for topical delivery. Int J Nanomedicine. 2018;13:2827-37.

  162. Sharma US, Balasubramanian SV, Straubinger RM. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. J Pharm Sci. 1995;84(10):1223-30.

  163. Nakamura J, Nakajima N, Matsumura K, Hyon SH. Water-soluble taxol conjugates with dextran and targets tumor cells by folic acid immobilization. Anti Cancer Res. 2010;30(3):903-9.

  164. Sparreboom A, Van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DK, Borst P, Nooijen WJ, Beijnen JH, Van Tellingen O. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2031-5.

  165. Tandon VR, Kapoor B, Bano G, Gupta S, Gillani Z, Kour D. P-glycoprotein: Pharmacological relevance. Indian J Pharmacol. 2006;38(1):13-24.

  166. Choudhury H, Gorain B, Karmakar S, Biswas E, Dey G, Barik R, Mandal M, Pal TK. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. Int J Pharm. 2014;460(1-2):131-43.

  167. Han M, He CX, Fang QL, Yang XC, Diao YY, Xu DH, He QJ, Hu YZ, Liang WQ, Yang B, Gao JQ. A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo. Pharm Res. 2009;26(4):926-35.

  168. Sari TP, Mann B, Kumar R, Singh RR, Sharma R, Bhardwaj M, Athira S. Preparation and characterization of nanoemulsion encapsulating curcumin. Food Hydrocoll. 2015;43:540-6.

  169. Tiwari SB, Amiji MM. Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol. 2006;6(9-10):3215-21.

  170. Alkhatib MH, Alkreathy HM, Balamash KS, Abdu F. Antitumor activity of doxorubicine-loaded nanoemulsion against Ehrlich ascites carcinoma-bearing mice. Trop J Pharm Res. 2016;15(5):937-43.

  171. Periasamy VS, Athinarayanan J, Alshatwi AA. Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells. Ultrason Sonochem. 2016;31:449-55.

  172. Elnaggar YS, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm. 2009;380(1-2):133-41.

  173. Fofaria NM, Qhattal HS, Liu X, Srivastava SK. Nanoemulsion formulations for anti-cancer agent piplartine: Characterization, toxicological, pharmacokinetics and efficacy studies. Int J Pharm. 2016;498(1-2):12-22.

  174. Tiwari R, Pandey V, Asati S, Soni V, Jain D. Therapeutic challenges in ocular delivery of lipid based emulsion. Egypt J Basic Appl Sci. 2018;5(2):121-9.

  175. Shen J, Liu X, Zhou M, Liu H. Novel nanoemulsion formulation for ocular drug delivery for cataract therapeutics. J Biomater Tissue Eng. 2018;8(5):647-57.

  176. Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech. 2009;10(3):808-19.

  177. Singh KK, Vingkar SK. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. Int J Pharm. 2008;347(1-2):136-43.

  178. Tang SY, Sivakumar M, Ng AM, Shridharan P. Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. Int J Pharm. 2012;430(1-2):299-306.

  179. Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies. Int J Pharm. 2011;413(1-2):245-53.

  180. Soliman KA, Ibrahim HK, Ghorab MM. Formulation of avanafil in a solid self-nanoemulsifying drug delivery system for enhanced oral delivery. Eur J Pharm Sci. 2016;93:447-55.

  181. Ke Z, Hou X, Jia XB. Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Design Dev Ther. 2016;10:2049.

  182. Akhtar J, Siddiqui HH, Fareed S, Badruddeen, Khalid M, Aqil M. Nanoemulsion: For improved oral delivery of repaglinide. Drug Deliv. 2016;23(6):2026-34.

  183. Chai F, Sun L, Ding Y, Liu X, Zhang Y, Webster TJ, Zheng C. A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability. Nanomedicine. 2016;11(14):1801-16.

  184. Boche M, Pokharkar V. Quetiapine nanoemulsion for intranasal drug delivery: Evaluation of braintargeting efficiency. AAPS PharmSciTech. 2017;18(3):686-96.

  185. Primo FL, Michieleto L, Rodrigues MA, Macaroff PP, Morais PC, Lacava ZG, Bentley MV, Tedesco AC. Magnetic nanoemulsions as drug delivery system for Foscan: Skin permeation and retention in vitro assays for topical application in photodynamic therapy (PDT) of skin cancer. J Magn Magn Mater. 2007;311(1):354-7.

  186. Kumar M, Misra A, Pathak K. Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery. PDA J Pharm Sci Technol. 2009;63(6):501-11.

  187. Patel G, Shelat P, Lalwani A. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment, Drug Deliv. 2016;23(8):3027-42.

  188. Wang X, Jiang Y, Wang YW, Huang MT, Ho CT, Huang Q. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem. 2008;108(2):419-24.

  189. Laxmi M, Bhardwaj A, Mehta S, Mehta A. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. Artif Cells Nanomed Biotechnol. 2015;43(5):334-44.

  190. Moghimi R, Ghaderi L, Rafati H, Aliahmadi A, McClements DJ. Superior antibacterial activity of nanoemulsion of Thymus daenensis essential oil against E. coli. Food Chem. 2016;194: 410-5.

  191. Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems-an overview. Acta Pharm Sin B. 2013;3(6):361-72.

  192. Lv LZ, Tong CQ, Lv Q, Tang XJ, Li LM, Fang QX, Yu J, Han M, Gao JQ. Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: In vitro and in vivo studies. Int J Nanomedicine. 2012;7:4099-107.

  193. Madene A, Jacquot M, Scher J, Desobry S. Flavour encapsulation and controlled release-a review. Int J Food Sci Technol. 2006;41(1):1-21.

  194. Karthik P, Ezhilarasi PN, Anandharamakrishnan C. Challenges associated in stability of food grade nanoemulsions. Crit Rev Food Sci Nutr. 2017;57(7):1435-50.

  195. Mahdi Jafari S, He Y, Bhandari B. Nano-emulsion production by sonication and microfluidization: A comparison. Int J Food Prop. 2006;9(3):475-85.

REFERENZIERT VON
  1. Tuteja Minkal , Nagpal Kalpana, Recent Advances and Prospects for Plant Gum-Based Drug Delivery Systems: A Comprehensive Review , Critical Reviews™ in Therapeutic Drug Carrier Systems, 40, 2, 2023. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain